LifeSci Biotechnology Clinical Trials Index
Effective at the market close on October 23, 2025, AKRO, ETNB, MRUS, MTSR and TRML will be removed from the LifeSci Biotechnology Clinical Trials Index and their values will be redistributed to the remaining index components based on their weights.
Each of these companies have agreed to be acquired in all cash or mostly cash transactions.